James Investment Research Inc. bought a new stake in Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 274 shares of the company’s stock, valued at approximately $27,000.
Several other hedge funds also recently modified their holdings of the business. JPMorgan Chase & Co. boosted its stake in Addus HomeCare by 12.3% during the 1st quarter. JPMorgan Chase & Co. now owns 19,005 shares of the company’s stock worth $1,773,000 after acquiring an additional 2,080 shares during the last quarter. US Bancorp DE boosted its stake in Addus HomeCare by 335.3% during the 1st quarter. US Bancorp DE now owns 3,744 shares of the company’s stock worth $349,000 after acquiring an additional 2,884 shares during the last quarter. MetLife Investment Management LLC boosted its stake in Addus HomeCare by 59.9% during the 1st quarter. MetLife Investment Management LLC now owns 8,394 shares of the company’s stock worth $783,000 after acquiring an additional 3,146 shares during the last quarter. Rhumbline Advisers boosted its stake in Addus HomeCare by 2.9% during the 1st quarter. Rhumbline Advisers now owns 42,780 shares of the company’s stock worth $3,991,000 after acquiring an additional 1,214 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Addus HomeCare by 14.1% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,731 shares of the company’s stock worth $1,281,000 after acquiring an additional 1,693 shares during the last quarter. Institutional investors own 97.42% of the company’s stock.
Insider Buying and Selling
In related news, CFO Brian Poff sold 598 shares of the business’s stock in a transaction on Monday, February 27th. The shares were sold at an average price of $104.15, for a total transaction of $62,281.70. Following the transaction, the chief financial officer now directly owns 27,274 shares in the company, valued at $2,840,587.10. The sale was disclosed in a filing with the SEC, which is available through this link. In other Addus HomeCare news, CFO Brian Poff sold 598 shares of the company’s stock in a transaction on Monday, February 27th. The shares were sold at an average price of $104.15, for a total value of $62,281.70. Following the transaction, the chief financial officer now directly owns 27,274 shares in the company, valued at $2,840,587.10. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael D. Wattenbarger sold 552 shares of the company’s stock in a transaction on Friday, February 24th. The shares were sold at an average price of $104.31, for a total transaction of $57,579.12. Following the completion of the transaction, the executive vice president now owns 8,225 shares in the company, valued at $857,949.75. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,647 shares of company stock worth $1,110,502. Insiders own 4.50% of the company’s stock.
Wall Street Analysts Forecast Growth
Addus HomeCare Price Performance
Shares of ADUS opened at $112.22 on Thursday. The company has a market cap of $1.81 billion, a price-to-earnings ratio of 39.38, a PEG ratio of 2.59 and a beta of 0.90. Addus HomeCare Co. has a 1-year low of $73.65 and a 1-year high of $114.99. The company’s fifty day simple moving average is $104.94 and its 200 day simple moving average is $104.36. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.21.
About Addus HomeCare
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled.
Featured Articles
- Get a free copy of the StockNews.com research report on Addus HomeCare (ADUS)
- Should Cheesecake Factory Stock Be On Your Menu?
- Buffett Reduces Taiwan Semiconductor Stake After This Happened
- Don’t Get Bullish On The S&P 500 Because Of The CPI Report
- Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
- Proterra Inc., A Penny Stock To Put On The Watchlist
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
